Related Parties	9 Months Ended
Sep. 30, 2021
Related Party Transactions [Abstract]
Related Parties	Note 13. Related Parties Linda Marsh, who is a member of the Company’s board of directors, is currently the Senior Executive Vice President of AHMC Healthcare Inc., or AHMC. The Company performs genetic testing and other testing services, on an arms-length basis, for AHMC, and the Company recognized $762,000 and $2.6 million in revenue in the three and nine months ended September 30, 2021, respectively. The Company recognized $1.3 million in revenue in the three and nine months ended September 30, 2020. As of September 30, 2021 and December 31, 2020, $724,000 and $1.8 million was owed to the Company by AHMC, which is included in trade accounts receivable, net, in the accompanying Condensed Consolidated Balance Sheets, in connection with this relationship. The Company and Fulgent Pharma LLC, the Company’s former subsidiary, are party to shared services arrangements where research and development, administrative services and office space and equipment are provided between the companies, on an arms-length basis. Ming Hsieh is the Manager and a member of Fulgent Pharma LLC. During the three and nine months ended September 30, 2021, the cost of research development services rendered by Fulgent Pharma LLC for the Company was $74,000 and $279,000, respectively. The cost of research development services rendered by Fulgent Pharma LLC for the Company was not significant during the three and nine months ended September 30, 2020. Amounts for services performed by the Company for Fulgent Pharma LLC were not significant during the three and nine months ended September 30, 2021 and 2020. As of September 30, 2021, and December 31, 2020, $634,000 and $409,000, respectively, were owed to Fulgent Pharma LLC by the Company, which are included in due to related parties as a component in other current liabilities in the accompanying Condensed Consolidated Balance Sheets, in connection with these relationships. The Chief Executive Officer and Chairman of the Company’s board of directors, Ming Hsieh, is the owner of PTJ Associates Inc., or PTJ. PTJ provides flight services to the Company on an arms-length basis. During the three and nine months ended September 30, 2021, the company incurred $65,000 and $142,000, respectively, in expenses for flights between California and Texas to transport employees and supplies. As of September 30, 2021, nothing was owed to PTJ by the Company. As of December 31, 2020, $94,000 was owed to PTJ by the Company, which is included in accounts payable in the accompanying Condensed Consolidated Balance Sheets.

Related Parties

9 Months Ended

Sep. 30, 2021

Note 13. Related Parties

Linda Marsh, who is a member of the Company’s board of directors, is currently the Senior Executive Vice President of AHMC Healthcare Inc., or AHMC. The Company performs genetic testing and other testing services, on an arms-length basis, for AHMC, and the Company recognized $762,000 and $2.6 million in revenue in the three and nine months ended September 30, 2021, respectively. The Company recognized $1.3 million in revenue in the three and nine months ended September 30, 2020. As of September 30, 2021 and December 31, 2020, $724,000 and $1.8 million was owed to the Company by AHMC, which is included in trade accounts receivable, net, in the accompanying Condensed Consolidated Balance Sheets, in connection with this relationship.

The Company and Fulgent Pharma LLC, the Company’s former subsidiary, are party to shared services arrangements where research and development, administrative services and office space and equipment are provided between the companies, on an arms-length basis. Ming Hsieh is the Manager and a member of Fulgent Pharma LLC. During the three and nine months ended September 30, 2021, the cost of research development services rendered by Fulgent Pharma LLC for the Company was $74,000 and $279,000, respectively. The cost of research development services rendered by Fulgent Pharma LLC for the Company was not significant during the three and nine months ended September 30, 2020. Amounts for services performed by the Company for Fulgent Pharma LLC were not significant during the three and nine months ended September 30, 2021 and 2020. As of September 30, 2021, and December 31, 2020, $634,000 and $409,000, respectively, were owed to Fulgent Pharma LLC by the Company, which are included in due to related parties as a component in other current liabilities in the accompanying Condensed Consolidated Balance Sheets, in connection with these relationships.

The Chief Executive Officer and Chairman of the Company’s board of directors, Ming Hsieh, is the owner of PTJ Associates Inc., or PTJ. PTJ provides flight services to the Company on an arms-length basis. During the three and nine months ended September 30, 2021, the company incurred $65,000 and $142,000, respectively, in expenses for flights between California and Texas to transport employees and supplies. As of September 30, 2021, nothing was owed to PTJ by the Company. As of December 31, 2020, $94,000 was owed to PTJ by the Company, which is included in accounts payable in the accompanying Condensed Consolidated Balance Sheets.